当前位置:首页 - 行情中心 - 卫光生物(002880) - 财务分析 - 现金流量表

卫光生物

(002880)

  

流通市值:62.12亿  总市值:62.12亿
流通股本:2.27亿   总股本:2.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金814,401,293.52537,973,211.97262,873,081.141,076,487,287.04
  收到的税费返还6,053,471.465,092,280.0197,457.1720,075,091.57
  收到其他与经营活动有关的现金22,213,009.425,860,354.363,532,288.4712,111,243.99
  经营活动现金流入小计842,667,774.4548,925,846.34266,502,826.781,108,673,622.6
  购买商品、接受劳务支付的现金415,014,230.45269,211,889.52134,334,845.84546,732,077.91
  支付给职工以及为职工支付的现金191,630,783.26145,646,351.0467,410,471.76212,937,138.47
  支付的各项税费91,362,801.7161,386,436.1629,380,044.58105,192,310.17
  支付其他与经营活动有关的现金53,539,557.6933,089,795.5814,144,655.9166,046,884.57
  经营活动现金流出小计751,547,373.11509,334,472.3245,270,018.09930,908,411.12
  经营活动产生的现金流量净额91,120,401.2939,591,374.0421,232,808.69177,765,211.48
二、投资活动产生的现金流量:
  取得投资收益收到的现金14,731,111.1114,657,611.115,356,555.562,130,000
  处置固定资产、无形资产和其他长期资产收回的现金净额3,6503,6503,650168,233.2
  收到的其他与投资活动有关的现金150,000,000140,000,00050,000,00020,000,000
  投资活动现金流入小计164,734,761.11154,661,261.1155,360,205.5622,298,233.2
  购建固定资产、无形资产和其他长期资产支付的现金139,923,297.6957,679,440.5730,351,184.34255,500,028.3
  投资支付的现金---5,000,000
  支付其他与投资活动有关的现金250,000,000250,000,000--
  投资活动现金流出小计389,923,297.69307,679,440.5730,351,184.34260,500,028.3
  投资活动产生的现金流量净额-225,188,536.58-153,018,179.4625,009,021.22-238,201,795.1
三、筹资活动产生的现金流量:
  取得借款收到的现金131,067,909.27104,710,324.84100,000,000252,762,337.03
  筹资活动现金流入小计131,067,909.27104,710,324.84100,000,000252,762,337.03
  偿还债务支付的现金129,308,020118,947,661110,360,35991,768,378.24
  分配股利、利润或偿付利息支付的现金61,909,163.210,490,308.985,239,611.5765,876,723.32
  支付其他与筹资活动有关的现金945,945623,700311,85011,394,896.3
  筹资活动现金流出小计192,163,128.2130,061,669.98115,911,820.57169,039,997.86
  筹资活动产生的现金流量净额-61,095,218.93-25,351,345.14-15,911,820.5783,722,339.17
五、现金及现金等价物净增加额-195,163,354.22-138,778,150.5630,330,009.3423,285,755.55
  加:期初现金及现金等价物余额274,730,437.06274,730,437.06274,730,437.06251,444,681.51
  期末现金及现金等价物余额79,567,082.84135,952,286.5305,060,446.4274,730,437.06
补充资料:
  净利润-107,575,098.85-253,956,996.52
  资产减值准备-13,543,662.61-5,344,625.37
  固定资产和投资性房地产折旧-64,781,868.86-108,529,942.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-64,781,868.86-108,529,942.62
  无形资产摊销-4,379,441.48-8,637,864.42
  长期待摊费用摊销-2,780,149.58-2,173,178.23
  处置固定资产、无形资产和其他长期资产的损失-0--45,819.96
  固定资产报废损失--8,339--100,166.54
  公允价值变动损失---14,050,642.96
  财务费用-9,965,736.16-22,754,150.06
  投资损失--2,022,539.02--5,516,759.51
  递延所得税--528,961.47--243,934.16
  其中:递延所得税资产减少--109,663.7-572,912.89
    递延所得税负债增加--419,297.77--816,847.05
  存货的减少--104,695,134.7--119,903,337.29
  经营性应收项目的减少-12,381,101.21--144,476,821.95
  经营性应付项目的增加--69,191,738.2-35,009,217.81
  其他----3,507,249.99
  现金的期末余额-135,952,286.5-274,730,437.06
  减:现金的期初余额-274,730,437.06-251,444,681.51
  现金及现金等价物的净增加额--138,778,150.56-23,285,755.55
公告日期2025-10-312025-08-302025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑